We have made an effort to determine whether or not there is any change in subpopulations of lymphocytes in normally pregnant and preeclamptic pregnancies using monoclonal antibody markers. Eleven normally pregnant and ten women with preeclampsia were studied, both during the third trimester and again two months postpartum, and compared to eleven age-matched nonpregnant women. Mononuclear cells were isolated from heparinized venous blood. One million cells were treated with each appropriate antibody (Ortho-mune OKM1, OKT3, OKT4, OKT8, OKT11, OKIa), and then reacted with FITC-antimouse IgG and examined by flow cytometry and/or fluorescence microscopy. No significant differences between these three groups were noted in the OKT3, OKT4, OKT8, OKT11, or OKIa cellular populations. The OKM1 population was significantly decreased in the third trimester of normal pregnancies but not in the preeclamptic pregnancies. No significant differences were found 2 months postpartum.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0897.1984.tb00284.xDOI Listing

Publication Analysis

Top Keywords

preeclamptic pregnancies
8
third trimester
8
months postpartum
8
okt3 okt4
8
okt4 okt8
8
okt8 okt11
8
okt11 okia
8
lymphocyte subpopulations
4
subpopulations normal
4
normal preeclampsia
4

Similar Publications

Background: MiR-519d-3p, also called specific placenta biomarkers, is a member of the Chromosome 19 miRNA Cluster (C19MC) with the highest concentrations of miRNAs in human placenta and maternal serum. These miRNAs are secreted by fetal trophoblast cells within extracellular vesicles (EVs) and interact with the mother's immune cells, which has been proposed to be crucial for immunological tolerance at the placental-maternal interface. A key mechanism in preeclampsia, a multifactorial, multipath hypertensive pregnancy illness, is an immunological imbalance between the mother and the fetus.

View Article and Find Full Text PDF

The overview of lactylation in the placenta of preeclampsia.

Placenta

January 2025

Department of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen, China; Shenzhen Key Laboratory on Technology for Early Diagnosis of Major Gynecological Diseases, Shenzhen, China. Electronic address:

Background: Preeclampsia is a major challenge for obstetricians due to its severe impacts on maternal and fetal health. Lysine lactylation (Kla) derived from lactate is a novel type of post-translational modification which has been confirmed to affect the malignant progression of diseases as an epigenetic modifier. However, the systemic lactylome profiling of preeclampsia is still unclear.

View Article and Find Full Text PDF

Preeclampsia (PE) is a multifactorial disorder of pregnancy, characterized by new-onset gestational hypertension. High-throughput mRNA sequencing (RNA-seq) was performed to analyze the gene expression patterns in placentas from patients with early-onset PE (EOPE). PR domain zinc-finger protein 1 (PRDM1) expression increased in the chorionic villi and placental basal plate from patients with PE and nitro--arginine methyl ester (L-NAME)-treated rats.

View Article and Find Full Text PDF

Objective: The aim of this study is to systematically examine the role of the pregnancy-associated plasma protein A (PAPP-A) serum biomarker in the first trimester screening of preeclampsia (PE).

Materials And Methods: A systematic search of the literature was conducted on PubMed via Medline, and Cochrane Library up to 8 November 2022, for prospective studies evaluating PAPP-A serum levels in first trimester pregnant women as a screening biomarker for PE. Eligible were all prospectively designed case-control or cohort studies, published in English.

View Article and Find Full Text PDF

Distinct phenotypes in the preeclamptic-like mouse model induced by adenovirus carrying sFlt1 and recombinant sFlt1 protein.

Eur J Med Res

December 2024

Clinical and Translational Research Center, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, 200092, China.

Background: Preeclampsia (PE) is a pregnancy-specific, multisystemic disorder that affects 2-8% pregnancies worldwide and is a leading cause of maternal and perinatal mortality. At present, there is no cure for PE apart from delivery the placenta. Therefore, it is important and urgent to possess a suitable animal model to study the pathology and treatment of PE.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!